- Patient currently is undergoing treatment for cancer
- Patient has menopausal symptoms induced either by surgical or medical (patient on tamoxifen or aromatase inhibitor) interventions for cancer
- Willing to stop other supplements or medications that are aimed at treating menopausal symptoms at least 7 days before beginning study treatment
- Menopausal symptoms are unrelated to surgical or medical treatment of breast or gynecologic cancers
Please contact Legacy Oncology Research for additional study inclusion/exclusion information.